WallStSmart

Accenture plc (ACN)vsConcentrix Corporation (CNXC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Accenture plc generates 624% more annual revenue ($72.11B vs $9.95B). ACN leads profitability with a 10.6% profit margin vs -13.3%. CNXC appears more attractively valued with a PEG of 0.25. ACN earns a higher WallStSmart Score of 62/100 (C+).

ACN

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 6.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.79

CNXC

Buy

52

out of 100

Grade: C-

Growth: 5.3Profit: 4.0Value: 8.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACNUndervalued (+10.0%)

Margin of Safety

+10.0%

Fair Value

$198.11

Current Price

$178.25

$19.86 discount

UndervaluedFair: $198.11Overvalued
CNXCUndervalued (+63.7%)

Margin of Safety

+63.7%

Fair Value

$95.87

Current Price

$27.82

$68.05 discount

UndervaluedFair: $95.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACN5 strengths · Avg: 8.6/10
Market CapQuality
$114.61B9/10

Large-cap with strong market position

Return on EquityProfitability
24.6%9/10

Every $100 of equity generates 25 in profit

Debt/EquityHealth
0.279/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$3.67B8/10

Generating 3.7B in free cash flow

CNXC2 strengths · Avg: 10.0/10
PEG RatioValuation
0.2510/10

Growing faster than its price suggests

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

Areas to Watch

ACN2 concerns · Avg: 3.5/10
EPS GrowthGrowth
4.0%4/10

4.0% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

CNXC4 concerns · Avg: 2.5/10
Market CapQuality
$1.60B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.703/10

Elevated debt levels

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

EPS GrowthGrowth
-68.4%2/10

Earnings declined 68.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : ACN

The strongest argument for ACN centers on Market Cap, Return on Equity, Debt/Equity. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bull Case : CNXC

The strongest argument for CNXC centers on PEG Ratio, Price/Book. PEG of 0.25 suggests the stock is reasonably priced for its growth.

Bear Case : ACN

The primary concerns for ACN are EPS Growth, Piotroski F-Score.

Bear Case : CNXC

The primary concerns for CNXC are Market Cap, Debt/Equity, Return on Equity. Debt-to-equity of 1.70 is elevated, increasing financial risk.

Key Dynamics to Monitor

ACN profiles as a value stock while CNXC is a turnaround play — different risk/reward profiles.

ACN carries more volatility with a beta of 1.07 — expect wider price swings.

ACN is growing revenue faster at 8.3% — sustainability is the question.

ACN generates stronger free cash flow (3.7B), providing more financial flexibility.

Bottom Line

ACN scores higher overall (62/100 vs 52/100). CNXC offers better value entry with a 63.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Accenture plc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Accenture plc is an Irish-domiciled multinational company that provides consulting and processing services. It has been incorporated in Dublin, Ireland since 2009.

Concentrix Corporation

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Concentrix Corporation offers global technology customer experience solutions. The company is headquartered in Fremont, California.

Visit Website →

Want to dig deeper into these stocks?